- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
REG
ASX
Week ended 07 Aug 2026
Weekly Investor Report
Regis Healthcare Limited · Healthcare · Medical Care Facilities
Latest close
6.30 AUD
1.1%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -0.9% below the Trend Line and sits at 18.6% of its 52-week range. The latest completed week returned 1.1%, after a -0.3% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is inexpensive relative to peers. The latest news-sentiment score is 52/100.
Setup score
32
out of 100
Latest Close
6.30 AUD
7 Aug 2026
1W Return
1.1%
latest completed week
4W Return
-0.3%
short-term follow-through
12W Return
1.8%
quarterly tape
Trend Breadth
13.5%
7 of 52 weeks active
Volume Ratio
1.1x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Activity pressure is weak, so confirmation is not yet broad enough.
- The share remains more than 20% below its 52-week high.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
1.1%
Latest completed week; four-week move -0.3%.
Indicator stack
7/50
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
52/100
38 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -0.9% below the Trend Line and sits at 18.6% of its 52-week range. The latest completed week returned 1.1%, after a -0.3% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.1x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.1312-week average 0.09
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure10/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.13Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -0.3% over four weeks, 1.8% over 12 weeks, and -26.5% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year7
Trend breadth13.5%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.24Latest activity-pressure read.
Pressure change-51.8%Four-week change in activity pressure.
Leadership-11.55Latest relative-leadership reading.
RS change-32.9%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is inexpensive relative to peers.
Factor week 09 Aug 2026
Financial statements through 30 Jun 2025
Field coverage 73%
Model confidence 37%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength45/100Blend of value, momentum, and quality. Underlying universe rank 56; rank 1 is best.
Value84/100Relative valuation strength. Underlying universe rank 17; rank 1 is best.
Quality14/100Profitability and accounting quality. Underlying universe rank 87; rank 1 is best.
Momentum8/100Medium-term price momentum. Underlying universe rank 93; rank 1 is best.
Growth87/100Revenue and earnings growth. Underlying universe rank 14; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 38.9x Price divided by trailing earnings.
- Price / sales
- 1.6x Market value relative to trailing revenue.
- EV / EBITDA
- 7.1x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 12.8% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 100.0% Gross profit retained from each unit of revenue.
- Operating margin
- 5.2% Operating profit retained from revenue.
- Free-cash-flow margin
- 18.9% Free cash flow generated from revenue.
- Return on invested capital
- - Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 14.5% Latest one-year revenue growth.
- EPS growth
- - Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- 17.7% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 3/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 2.7% Cash dividends relative to market value.
- Buyback yield
- 0.0% Net share repurchases relative to market value.
- Shareholder yield
- 2.7% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- -0.8x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment52/100
Weighted news tone is neutral across 38 relevant articles.
7 positive · 29 neutral · 2 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-32.1%Distance below the 52-week high.
13-week volatility4.1%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher12 of 2613 weeks finished lower.
Best week+15.4%Week of 24 Apr.
Worst week-7.3%Week of 13 Mar.
Latest week+1.1%Week of 7 Aug.
Shape of recent returns
Strong gains4
Modest gains8
Flat weeks1
Modest losses7
Sharp losses6
Recent vol4.1%13-week weekly-return volatility.
Base vol6.6%52-week weekly-return volatility.
Up/down split21/30Count of positive and negative weeks in the 52-week window.
Average skew5.0% / -4.1%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorAU Healthcare
4-week rank46 / 100
Group average-0.9%
Trend breadth25.0%
Trend25.0%active weekly trend signals
MD58.0%positive activity pressure
RS26.0%positive relative leadership
Four-week leaders
IndustryAU Medical Care Facilities
4-week rank2 / 4
Group average-0.7%
Trend breadth25.0%
Trend25.0%active weekly trend signals
MD100.0%positive activity pressure
RS25.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape28/100
Trend, activity pressure, participation, and risk combine to a 28/100 tape read.
Indicator analysis28/100Latest 12-week confirmation: trend 0/12, activity pressure 10/12, relative leadership 0/12.
Activity pressure 0.13; No reversal markers Factors37/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 61; Small Cap Core rank 26 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment52/100Weighted news tone is neutral across 38 relevant articles.
Regis Healthcare Ltd. Actuals & Estimates (ASX:REG) Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 6.30 AUD | 1.1% | 6.35 AUD | 5.49 AUD | 0.24 | -11.55 | 2.4M | Off |
| 31 Jul 2026 | 6.23 AUD | 1.8% | 6.37 AUD | 5.46 AUD | 0.33 | -10.40 | 1.8M | Off |
| 24 Jul 2026 | 6.12 AUD | 0.5% | 6.39 AUD | 5.44 AUD | 0.54 | -10.50 | 1.9M | Off |
| 17 Jul 2026 | 6.09 AUD | -3.6% | 6.42 AUD | 5.41 AUD | 0.60 | -11.63 | 4.3M | Off |
| 10 Jul 2026 | 6.32 AUD | -6.0% | 6.46 AUD | 5.38 AUD | 0.50 | -8.69 | 3.5M | Off |
| 3 Jul 2026 | 6.72 AUD | 3.2% | 6.49 AUD | 5.36 AUD | 0.20 | -3.58 | 693.1K | Off |
| 26 Jun 2026 | 6.51 AUD | 6.0% | 6.52 AUD | 5.33 AUD | -0.05 | -5.95 | 491.4K | Off |
| 19 Jun 2026 | 6.14 AUD | 3.2% | 6.56 AUD | 5.30 AUD | -0.07 | -12.23 | 1.2M | Off |
| 12 Jun 2026 | 5.95 AUD | -4.0% | 6.60 AUD | 5.27 AUD | 0.05 | -15.10 | 311.1K | Off |
| 5 Jun 2026 | 6.20 AUD | -5.8% | 6.64 AUD | 5.24 AUD | 0.29 | -10.06 | 1.9M | Off |
| 29 May 2026 | 6.58 AUD | 7.3% | 6.69 AUD | 5.22 AUD | 0.45 | -6.04 | 683.6K | Off |
| 22 May 2026 | 6.13 AUD | -1.0% | 6.71 AUD | 5.19 AUD | 0.52 | -12.11 | 4.6M | Off |
| 15 May 2026 | 6.19 AUD | -2.5% | 6.74 AUD | 5.16 AUD | 0.68 | -11.38 | 4.8M | Off |
| 8 May 2026 | 6.35 AUD | -5.1% | 6.75 AUD | 5.14 AUD | 0.34 | -10.66 | 3.9M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.